Search

Issue
Title
Authors
Vol 31, No 2 (2024)
Vildagliptin – 15 years in active service with diabetologists
Pavlova M.G.
PDF
(Rus)
No 3 (2009)
Vildagliptin - a new dipeptidylpeptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
Antsiferov M.B., Dorofeeva L.G., Anciferov M.B., Dorofeeva L.G.
Vol 26, No 14 (2019)
Start of therapy of type 2 diabetes mellitus with a fixed combination. Metformin with vildagliptin or glibenclamide, is there any difference?
Demidov N.A., Koteshkova O.M., Balberova M.A., Antsiferov M.B.
PDF
(Rus)
No 3 (2012)
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
No 17 (2015)
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Nikitina T.P., Rodionova A.Y., Kurbatova K.A., Ionova T.I.
PDF
(Rus)
No 16 (2011)
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M.B., Antciferov M.B.
No 5 (2015)
Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa
Antsiferov M.B.
PDF
(Rus)
No 16 (2011)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M.B., Antciferov M.B.
No 5 (2014)
VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Abaeva M.S., Nazhmutdinova P.K., Ametov A.S.
PDF
(Rus)
No 3 (2011)
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
Antsiferov M.B., Antsiferov M.B.
No 5 (2013)
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E.E., Rashid M.A., Antsiferov M.B.
PDF
(Rus)
No 16 (2010)
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M.B., Zilov A.V., Antsiferov M.B., Zilov A.V.
No 10 (2012)
Vliyanie ingibitorov dipeptidilpepti-dazy-4 na funktsional'noe sostoyanie miokarda u bol'nykh sakharnym diabetom 2 tipa
Ametov A.S., Kulidzhanyan N.K., Shurupova I.V., Trifonova T.A., Antsiferov M.B.
PDF
(Rus)
No 3 (2010)
New possibilities for type 2 diabetes mellitus therapy. Results of a pilot observation program of efficacy and safety of the drug «Galvus» (vildagliptin) therapy in Moscow and in the regions of the Russian Federation
Pavlova M.G., Pavlova M.
No 7 (2012)
DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY?
Antsiferov M.B., Ametov A.S., Zilov A.V., Antsiferov M.B., Ametov A.S., Zilov A.V.
Vol 29, No 11/12 (2022)
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
Pavlova M.G.
PDF
(Rus)
No 7 (2012)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M.B., Antsiferov M.B.
1 - 17 of 17 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies